FlashFeed

MS Drug Fampridine Now Available on NHS England — Up to 5,000 Patients Eligible

Fampridine, a drug that boosts nerve signals to make walking easier for multiple sclerosis patients, has been approved for NHS funding in England. Up to 5,000 patients are estimated to be eligible for the treatment. The drug has been described as life-changing for those who struggle with mobility due to MS.